HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Giotta Selected Research

Leptin

11/2013Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Giotta Research Topics

Disease

47Breast Neoplasms (Breast Cancer)
03/2024 - 06/2002
26Neoplasms (Cancer)
01/2023 - 05/2006
7Neoplasm Metastasis (Metastasis)
07/2022 - 07/2006
5Triple Negative Breast Neoplasms
01/2023 - 09/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2005 - 10/2002
2Diarrhea
03/2023 - 02/2013
2Thrombosis (Thrombus)
08/2022 - 01/2022
2Obesity
11/2020 - 08/2019
2Hypertension (High Blood Pressure)
08/2019 - 01/2012
2Brain Neoplasms (Brain Tumor)
01/2019 - 05/2006
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2023
1Seminoma
08/2022
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2022
1Inflammation (Inflammations)
07/2022
1Tachycardia (Tachyarrhythmias)
04/2022
1Ventricular Tachycardia
04/2022
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2021
1COVID-19
05/2021
1Nausea
01/2020
1Motion Sickness (Airsickness)
01/2020
1Vomiting
01/2020
1Endometrial Neoplasms (Endometrial Cancer)
10/2019
1Thyroid Neoplasms (Thyroid Cancer)
08/2019
1Atrial Fibrillation
08/2019
1Papillary Thyroid Cancer
08/2019
1Bone Diseases (Bone Disease)
01/2018
1Disease Progression
01/2018
1Male Breast Neoplasms (Male Breast Cancer)
11/2016

Drug/Important Bio-Agent (IBA)

10Trastuzumab (Herceptin)FDA Link
11/2023 - 01/2012
6Hormones (Hormone)IBA
03/2023 - 09/2012
6human ERBB2 proteinIBA
01/2021 - 01/2012
6pertuzumabIBA
01/2021 - 01/2017
5Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 06/2012
5Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 06/2002
5Docetaxel (Taxotere)FDA Link
04/2014 - 10/2002
5Epirubicin (Ellence)FDA LinkGeneric
11/2013 - 06/2002
4Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 11/2005
4AnthracyclinesIBA
04/2011 - 06/2002
3ErbB Receptors (EGF Receptor)IBA
11/2023 - 03/2023
3Capecitabine (Xeloda)FDA Link
01/2023 - 11/2013
3Epidermal Growth Factor (EGF)IBA
01/2021 - 02/2013
3Ado-Trastuzumab EmtansineIBA
01/2021 - 01/2017
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020 - 02/2013
3sodium-hydrogen exchanger regulatory factorIBA
02/2020 - 09/2017
3Estrogens (Estrogen)FDA Link
10/2014 - 06/2012
3GemcitabineFDA Link
04/2014 - 10/2002
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2022 - 01/2022
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2020
2Estrogen ReceptorsIBA
01/2021 - 09/2012
2eribulinFDA Link
01/2021 - 11/2016
2taxaneIBA
10/2019 - 01/2019
2Phenobarbital (Luminal)FDA Link
04/2016 - 06/2012
2Peptides (Polypeptides)IBA
11/2013 - 02/2013
2GhrelinIBA
11/2013 - 02/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2011 - 06/2002
1abemaciclibIBA
03/2023
1Cyclin-Dependent Kinase 4IBA
03/2023
1palbociclibIBA
10/2022
1edoxabanIBA
08/2022
1Enoxaparin (Lovenox)FDA LinkGeneric
08/2022
1AnticoagulantsIBA
08/2022
1Adenosine Triphosphate (ATP)IBA
07/2022
1Adenosine (Adenocard)FDA LinkGeneric
07/2022
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Tinzaparin (Innohep)FDA Link
01/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
05/2021
1CytokinesIBA
01/2021
1InflammasomesIBA
01/2021
1Indicators and Reagents (Reagents)IBA
11/2020
1Palonosetron (Aloxi)FDA Link
01/2020
1netupitantIBA
01/2020
1Biological FactorsIBA
11/2019
1Androgen Receptors (Androgen Receptor)IBA
09/2019
1IodineIBA
08/2019
1lenvatinibIBA
08/2019
1CateninsIBA
07/2019
1Taxoids (Taxanes)IBA
01/2019
1130-nm albumin-bound paclitaxelIBA
01/2018
1Diphosphonates (Bisphosphonates)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
09/2017
1exemestane (Aromasin)FDA Link
06/2017
1EverolimusFDA Link
06/2017
1Poly (ADP-Ribose) Polymerase-1IBA
05/2016
1Adenosine Diphosphate (ADP)IBA
05/2016
1Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2016
1BRCA1 ProteinIBA
05/2016
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
05/2016
1MotilinIBA
11/2013
1LeptinIBA
11/2013
1Lapatinib (GW572016)FDA Link
11/2013
1GastrinsIBA
11/2013

Therapy/Procedure

20Therapeutics
11/2023 - 01/2012
19Drug Therapy (Chemotherapy)
11/2023 - 06/2002
5Neoadjuvant Therapy
03/2024 - 04/2021
4Adjuvant Chemotherapy
10/2014 - 06/2012
2Immunotherapy
01/2022 - 02/2020
1Polypharmacy
03/2023
1Catheter Ablation
04/2022